Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Sex Transm Dis. 2020 Apr;47(4):243–245. doi: 10.1097/OLQ.0000000000001139

Table.

Specimen Positivity by Sex, Pathogen and Anatomic Site

Urogenital-Only Positive # (%) Rectal-Only Positive # (%) Positive on Both # (%) Total Positive # (%) %Missed without Rectal Testin^

Females (N=462):
 Chlamydia 12 (2.6) 13 (2.8) 9 (1.9) 34 (7.4) 38.2
 Gonorrhea 0 (0.0) 1 (100.0) 0 (0.0) 1 (0.2) 100.0
 Trichomonas 22 (4.8) 19 (4.1) 4 (0.9) 45 (9.9) 42.2
*Any of the above 29 (6.3) 28 (6.1) 15 (3.2) 72 (15.6) 38.4

Males (N=419)
 Chlamydia 17 (4.1) 21 (5.0) 1 (0.2) 39 (9.3) 53.8
 Gonorrhea 2 (0.5) 25 (6.0) 0 (0.0) 27 (6.4) 92.6
 Trichomonas 0 (0.0) 2 (0.5) 1 (0.2) 3 (0.7) 66.7
*Any of the above 8 (4.3) 9 (9.3) (0.7) 0 (14.3) 5.0

Total (N=881)
 Chlamydia 29 (3.3) 34 (3.9) 10 (1.1) 73 (8.3) 46.6
 Gonorrhea 2 (0.2) 26 (3.0) 0 (0.0) 28 (3.2) 92.9
 Trichomonas 22 (2.5) 21 (2.4) 5 (0.6) 48 (5.5) 43.8
*Any of the above 47 (5.3) 67 (7.6) 18 (2.0) 132 (15.0) 50.8
^

%Missed=#Identified exclusively through rectal testing/Total # Identified through rectal or urogenital testing

*

Results for Any STI differ from the summation of individual STI results due to coinfections (n=17: 9 CT/TV coinfections and 8 CT/NG coinfections)